BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20388872)

  • 1. Treatment and risk in heart failure: gaps in evidence or quality?
    Peterson PN; Rumsfeld JS; Liang L; Hernandez AF; Peterson ED; Fonarow GC; Masoudi FA;
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):309-15. PubMed ID: 20388872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
    Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
    Forman DE; Cannon CP; Hernandez AF; Liang L; Yancy C; Fonarow GC;
    Am Heart J; 2009 Jun; 157(6):1010-7. PubMed ID: 19464411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
    Ahmed A; Centor RM; Weaver MT; Perry GJ
    Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.
    Witham MD; Gillespie ND; Struthers AD
    Age Ageing; 2004 Sep; 33(5):467-72. PubMed ID: 15217777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
    Rangaswamy C; Finn JI; Koelling TM
    Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC; Gheorghiade M; Abraham WT
    Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project.
    Goff DC; Massing MW; Bertoni AG; Davis J; Ambrosius WT; McArdle J; Duren-Winfield V; Sueta CA; Croft JB
    Am Heart J; 2005 Oct; 150(4):717-24. PubMed ID: 16209973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
    Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.